Biosimulation software and services for drug discovery and development
Certara is a public company delivering biosimulation and modeling tools to accelerate pharmaceutical R&D. The tech stack is production-grade—R, SAS, Python, Go, and AWS container orchestration (EKS, ECS, Lambda)—paired with CI/CD infrastructure (GitLab, Argo CD, Terraform). Active hiring skews senior and leadership-heavy across engineering and support, while projects focus on regulatory submission automation, PBPK modeling integration across discovery-to-clinical workflows, and AI adoption in data platforms, signaling investment in both customer-facing product depth and internal operational scaling.
Notable leadership hires: Chief of Staff
Certara provides biosimulation software, scientific informatics, and consulting services for pharmaceutical and biotech companies navigating drug discovery and clinical development. The company serves approximately 2,000 biopharmaceutical organizations, academic institutions, and regulatory agencies across 62 countries. Its core offerings span PK/PD and PBPK modeling, trial design support, regulatory writing, and quantitative systems pharmacology. Certara operates at scale with 1,001–5,000 employees based primarily in Radnor, Pennsylvania, and distributed across the United States, Hungary, United Kingdom, Philippines, Indonesia, Netherlands, Germany, and Switzerland.
Core languages: R, SAS, Python, Go, Java, C#. Infrastructure: AWS (EKS, ECS, Lambda, CloudFormation, API Gateway), Kubernetes, Docker, Terraform. CI/CD: GitLab, Argo CD. Frontend: Angular, React. Adopting Phoenix.
Current projects include PBPK modeling integration across discovery-to-clinical workflows, electronic submission publishing and package development, state-of-the-art PK/PD analysis, regulatory documentation automation, and adoption of AI solutions in chemical and biological data management platforms.
Other companies in the same industry, closest in size